Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

InMed Pharmaceuticals (INM) Shares Outstanding (Diluted Average): 2023-2025

Historic Shares Outstanding (Diluted Average) for InMed Pharmaceuticals (INM) over the last 3 years, with Jun 2025 value amounting to $975,985.

  • InMed Pharmaceuticals' Shares Outstanding (Diluted Average) rose 537.70% to $4.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.0 million, marking a year-over-year increase of 537.70%. This contributed to the annual value of $975,985 for FY2025, which is 156.13% up from last year.
  • As of FY2025, InMed Pharmaceuticals' Shares Outstanding (Diluted Average) stood at $975,985, which was up 156.13% from $381,053 recorded in FY2024.
  • In the past 5 years, InMed Pharmaceuticals' Shares Outstanding (Diluted Average) ranged from a high of $2.4 million in FY2023 and a low of $381,053 during FY2024.
  • For the 3-year period, InMed Pharmaceuticals' Shares Outstanding (Diluted Average) averaged around $1.3 million, with its median value being $975,985 (2025).
  • In the last 5 years, InMed Pharmaceuticals' Shares Outstanding (Diluted Average) plummeted by 84.44% in 2024 and then skyrocketed by 156.13% in 2025.
  • InMed Pharmaceuticals' Shares Outstanding (Diluted Average) (Yearly) stood at $2.4 million in 2023, then crashed by 84.44% to $381,053 in 2024, then skyrocketed by 156.13% to $975,985 in 2025.